FdaApplication

ANDA 209796

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHETERO LABS LTD UNIT III
application_typeANDA
approval_date2020-02-24

Products (1)

ProductActive ingredientStrengthDosage form
CLOBAZAMCLOBAZAM2.5MG/MLSUSPENSION;ORAL

1 product